Skip to main content
Erschienen in: Intensive Care Medicine 3/2012

01.03.2012 | Original

Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?

verfasst von: Perrine Hoet, Vincent Haufroid, Gladys Deumer, Xavier Dumont, Dominique Lison, Philippe Hantson

Erschienen in: Intensive Care Medicine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

A significant fraction of patients with acute liver failure (ALF) suffer from a concomitant acute kidney injury (AKI), the mechanism of which is probably multifactorial. Cadmium (Cd) is a widespread environmental pollutant and a tubulotoxic metal that accumulates in the liver. We tested the hypothesis that a release of Cd during ALF may cause a redistribution of Cd from the liver to the kidneys and play a role in the occurrence of ALF-associated AKI.

Methods

Twenty patients with ALF (ALF-patients), 20 patients from the ICU with no liver damage at admission (ICU-controls) and 20 healthy controls were recruited to compare the 24-h urinary excretion rate of Cd with that of lead (Pb), a nephrotoxic metal that does not accumulate in the liver, and zinc (Zn), a non-nephrotoxic element found in high amounts in the liver. The excretion rates of the low-molecular-weight proteins (LMWPs) were monitored.

Results

ALF-patients excreted markedly more Cd than the healthy controls and ICU-controls. In ALF-patients, the four urinary LMWPs (RBP, β2-MG, CC16 and α1-MG) increased as a function of Cd excretion, with high correlation coefficients. The prevalence of patients excreting a high amount of LMWPs also increased with increasing Cd excretion. No relationship was found between the other elements investigated and the LMWPs, with the exception of copper, which shares close toxicokinetic similarities with Cd.

Conclusions

This study shows a strong association between urinary Cd levels and the excretion rates of LMWPs in patients with ALF. A causal relationship is possible but could not be fully demonstrated in this study.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat McKinnell J, Holt S (2007) Liver disease and renal dysfunction. Medicine 35:521–523CrossRef McKinnell J, Holt S (2007) Liver disease and renal dysfunction. Medicine 35:521–523CrossRef
2.
Zurück zum Zitat Moore K (1999) Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 11:967–975PubMedCrossRef Moore K (1999) Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 11:967–975PubMedCrossRef
3.
Zurück zum Zitat Eguia L, Materson BJ (1997) Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 17:363–370PubMed Eguia L, Materson BJ (1997) Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 17:363–370PubMed
4.
Zurück zum Zitat Hengy B, Hayi-Slayman D, Page M, Christin F, Baillon JJ, Ber CE, Allaouchiche B, Rimmelé T (2009) Acute renal failure after acetaminophen poisoning: report of three cases. Can Anaesth 56:770–774CrossRef Hengy B, Hayi-Slayman D, Page M, Christin F, Baillon JJ, Ber CE, Allaouchiche B, Rimmelé T (2009) Acute renal failure after acetaminophen poisoning: report of three cases. Can Anaesth 56:770–774CrossRef
5.
Zurück zum Zitat Mazer M, Perrone J (2008) Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 4:2–6PubMedCrossRef Mazer M, Perrone J (2008) Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 4:2–6PubMedCrossRef
6.
Zurück zum Zitat Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–143PubMedCrossRef Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–143PubMedCrossRef
7.
Zurück zum Zitat Jarup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201–208PubMedCrossRef Jarup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201–208PubMedCrossRef
9.
Zurück zum Zitat European Chemicals Bureau (2007) European Union risk assessment report cadmium metal and cadmium oxide. Office for Official Publications of the European Communities, vol 74. EUR 22767 EN. European Union, Luxembourg European Chemicals Bureau (2007) European Union risk assessment report cadmium metal and cadmium oxide. Office for Official Publications of the European Communities, vol 74. EUR 22767 EN. European Union, Luxembourg
10.
Zurück zum Zitat Cain K, Griffiths B (1980) Transfer of liver cadmium to the kidney after aflatoxin induced liver damage. Biochem Pharmacol 29:1852–1855PubMedCrossRef Cain K, Griffiths B (1980) Transfer of liver cadmium to the kidney after aflatoxin induced liver damage. Biochem Pharmacol 29:1852–1855PubMedCrossRef
11.
Zurück zum Zitat Chan HM, Zhu LF, Zhong R, Grant D, Goyer RA, Cherian MG (1993) Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol Appl Pharmacol 123:89–96PubMedCrossRef Chan HM, Zhu LF, Zhong R, Grant D, Goyer RA, Cherian MG (1993) Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol Appl Pharmacol 123:89–96PubMedCrossRef
12.
Zurück zum Zitat Bernard AM, Lauwerys RR (1981) The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats. Toxicol Appl Pharmacol 57:30–38PubMedCrossRef Bernard AM, Lauwerys RR (1981) The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats. Toxicol Appl Pharmacol 57:30–38PubMedCrossRef
13.
Zurück zum Zitat Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P (2005) Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39:1353–1357PubMedCrossRef Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P (2005) Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39:1353–1357PubMedCrossRef
14.
Zurück zum Zitat Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106PubMedCrossRef Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106PubMedCrossRef
15.
Zurück zum Zitat Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute kidney injury network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCrossRef Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute kidney injury network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31PubMedCrossRef
16.
Zurück zum Zitat Bernard A, Lauwerys RR (1983) Continuous flow system for the automation of latex immunoassay. Clin Chem 29:1007–1011PubMed Bernard A, Lauwerys RR (1983) Continuous flow system for the automation of latex immunoassay. Clin Chem 29:1007–1011PubMed
17.
Zurück zum Zitat Lauwerys R, Hoet P (2001) Industrial chemical exposure: guidelines for biological monitoring. 3rd edn. Lewis Publ, Boca Raton Lauwerys R, Hoet P (2001) Industrial chemical exposure: guidelines for biological monitoring. 3rd edn. Lewis Publ, Boca Raton
18.
Zurück zum Zitat Finn W, Porter G (2008) Urinary biomarkers and nephrotoxicity. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 91–130 Finn W, Porter G (2008) Urinary biomarkers and nephrotoxicity. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 91–130
19.
Zurück zum Zitat Bernard A (2004) Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17:519–523PubMedCrossRef Bernard A (2004) Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17:519–523PubMedCrossRef
20.
Zurück zum Zitat Nordberg GF, Kido T, Roels H (2008) Cadmium-induced renal effects. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 785–810 Nordberg GF, Kido T, Roels H (2008) Cadmium-induced renal effects. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 785–810
21.
Zurück zum Zitat EL-Safty IAM, Afifi AMH, Shouman AE, EL-Sady AKR (2004) Effects of smoking and lead exposure on proximal tubular integrity among egyptian industrial workers. Arch Med Res 35:59–65PubMedCrossRef EL-Safty IAM, Afifi AMH, Shouman AE, EL-Sady AKR (2004) Effects of smoking and lead exposure on proximal tubular integrity among egyptian industrial workers. Arch Med Res 35:59–65PubMedCrossRef
22.
Zurück zum Zitat Melichar B, Jandik P, Malir F, Vavrova J, Bures J, Mergancova J, Voboril Z (1995) Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Invest 55:149–152PubMedCrossRef Melichar B, Jandik P, Malir F, Vavrova J, Bures J, Mergancova J, Voboril Z (1995) Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Invest 55:149–152PubMedCrossRef
23.
Zurück zum Zitat Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, Guenther MJ, Prasad AS (1989) Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31:87–90PubMedCrossRef Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, Guenther MJ, Prasad AS (1989) Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31:87–90PubMedCrossRef
24.
Zurück zum Zitat Dorian C, Gattone VH, Klaassen CD (1995) Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 130:161–168PubMedCrossRef Dorian C, Gattone VH, Klaassen CD (1995) Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 130:161–168PubMedCrossRef
25.
Zurück zum Zitat Vestergaard P, Shaikh ZA (1994) The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol 126:240–247PubMedCrossRef Vestergaard P, Shaikh ZA (1994) The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol 126:240–247PubMedCrossRef
26.
Zurück zum Zitat Liu J, Habeebu SS, Liu Y, Klaassen CD (1998) Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Toxicol Appl Pharmacol 153:48–58PubMedCrossRef Liu J, Habeebu SS, Liu Y, Klaassen CD (1998) Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Toxicol Appl Pharmacol 153:48–58PubMedCrossRef
27.
Zurück zum Zitat Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 24[Suppl]1:1–51 Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 24[Suppl]1:1–51
28.
Zurück zum Zitat Bem EM, Piotrowski JK, Sobczak-Kozlowska M, Dmuchowski C (1988) Cadmium, zinc, copper and metallothionein levels in human liver. Int Arch Occup Environ Health 60:413–417PubMedCrossRef Bem EM, Piotrowski JK, Sobczak-Kozlowska M, Dmuchowski C (1988) Cadmium, zinc, copper and metallothionein levels in human liver. Int Arch Occup Environ Health 60:413–417PubMedCrossRef
29.
Zurück zum Zitat Orlowski C, Piotrowski JK (1998) Metal composition of human hepatic and renal metallothionein. Biol Trace Elem Res 65:133–141PubMedCrossRef Orlowski C, Piotrowski JK (1998) Metal composition of human hepatic and renal metallothionein. Biol Trace Elem Res 65:133–141PubMedCrossRef
30.
Zurück zum Zitat Dudley RE, Gammal LM, Klaassen CD (1985) Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol Appl Pharmacol 77:414–426PubMedCrossRef Dudley RE, Gammal LM, Klaassen CD (1985) Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol Appl Pharmacol 77:414–426PubMedCrossRef
31.
Zurück zum Zitat Nomiyama K, Nomiyama H, Kameda N (1998) Plasma cadmium-metallothionein, a biological exposure index for cadmium-induced renal dysfunction, based on the mechanism of its action. Toxicology 129:157–168PubMedCrossRef Nomiyama K, Nomiyama H, Kameda N (1998) Plasma cadmium-metallothionein, a biological exposure index for cadmium-induced renal dysfunction, based on the mechanism of its action. Toxicology 129:157–168PubMedCrossRef
32.
Zurück zum Zitat Tanaka K (1982) Effects of hepatic disorder on the fate of cadmium in rats. Dev Toxicol Environ Sci 9:237–249PubMed Tanaka K (1982) Effects of hepatic disorder on the fate of cadmium in rats. Dev Toxicol Environ Sci 9:237–249PubMed
33.
Zurück zum Zitat Nakajima M, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Inaba T, Kido T, Shaikh ZA, Nogawa K (2005) Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res 108:17–31PubMedCrossRef Nakajima M, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Inaba T, Kido T, Shaikh ZA, Nogawa K (2005) Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res 108:17–31PubMedCrossRef
34.
Zurück zum Zitat Ikeda M, Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T (2007) Changes in tubular dysfunction marker levels in parallel with the levels of copper, rather than cadmium, in urine of middle-aged women in non-polluted areas. Int Arch Occup Environ Health 80:171–183PubMedCrossRef Ikeda M, Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T (2007) Changes in tubular dysfunction marker levels in parallel with the levels of copper, rather than cadmium, in urine of middle-aged women in non-polluted areas. Int Arch Occup Environ Health 80:171–183PubMedCrossRef
35.
Zurück zum Zitat Nomiyama K, Nomiyama H, Kameda N, Tsuji A, Sakurai H (1999) Mechanism of hepatorenal syndrome in rats of Long–Evans Cinnamon strain, an animal model of fulminant Wilson’s disease. Toxicology 132:201–214PubMedCrossRef Nomiyama K, Nomiyama H, Kameda N, Tsuji A, Sakurai H (1999) Mechanism of hepatorenal syndrome in rats of Long–Evans Cinnamon strain, an animal model of fulminant Wilson’s disease. Toxicology 132:201–214PubMedCrossRef
36.
Zurück zum Zitat Lin JL, Lin-Tan DT, Chu PH, Chen YC, Huang YL, Ho TC, Lin CY (2009) Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients. Crit Care Med 37:957–962PubMedCrossRef Lin JL, Lin-Tan DT, Chu PH, Chen YC, Huang YL, Ho TC, Lin CY (2009) Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients. Crit Care Med 37:957–962PubMedCrossRef
Metadaten
Titel
Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?
verfasst von
Perrine Hoet
Vincent Haufroid
Gladys Deumer
Xavier Dumont
Dominique Lison
Philippe Hantson
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2012
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2449-0

Weitere Artikel der Ausgabe 3/2012

Intensive Care Medicine 3/2012 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.